VPAResearch: Market Research Reports

VPA Research is one of the global pharmaceutical companies specialized in analysis of clinical trials. We provide leading insights into global Pharma products, pipeline research, companies and drugs markets.

Publications found: 61,464
Sort by:

2019 Future of Hypoparathyroidism R&D Pipeline Drugs and Companies- Analysis of Global Hypoparathyroidism Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... advancing their products into Phase 3 or Phase 4. Hypoparathyroidism Report Description The H1 2019 pipeline review report on Hypoparathyroidism pipeline is a comprehensive study on the candidates in development ...

January 2019 40 pages

2019 Future of Hypotension R&D Pipeline Drugs and Companies- Analysis of Global Hypotension Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... advancing their products into Phase 3 or Phase 4. Hypotension Report Description The H1 2019 pipeline review report on Hypotension pipeline is a comprehensive study on the candidates in development ...

January 2019 50 pages

2019 Future of Hypothyroidism R&D Pipeline Drugs and Companies- Analysis of Global Hypothyroidism Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... advancing their products into Phase 3 or Phase 4. Hypothyroidism Report Description The H1 2019 pipeline review report on Hypothyroidism pipeline is a comprehensive study on the candidates in development ...

January 2019 35 pages

2019 Future of Intermittent Claudication R&D Pipeline Drugs and Companies- Analysis of Global Intermittent Claudication Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... advancing their products into Phase 3 or Phase 4. Intermittent Claudication Report Description The H1 2019 pipeline review report on Intermittent Claudication pipeline is a comprehensive study on the candidates in development ...

January 2019 55 pages

2019 Future of Ischemia Reperfusion Injury R&D Pipeline Drugs and Companies- Analysis of Global Ischemia Reperfusion Injury Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... Phase 3 or Phase 4. Ischemia Reperfusion Injury Report Description The H1 2019 pipeline review report on Ischemia Reperfusion Injury pipeline is a comprehensive ... detailed analysis on all active Ischemia Reperfusion Injury pipeline compounds. The Ischemia Reperfusion Injury pipeline guide presents information ...

January 2019 100 pages

2019 Future of Keloids R&D Pipeline Drugs and Companies- Analysis of Global Keloids Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... of the Keloids pipeline companies from advancing their products into Phase 3 or Phase 4. Keloids Report Description The H1 2019 pipeline review ... report on Keloids pipeline is a comprehensive study on the candidates ...

January 2019 40 pages

2019 Future of Left Ventricular Dysfunction R&D Pipeline Drugs and Companies- Analysis of Global Left Ventricular Dysfunction Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... Phase 3 or Phase 4. Left Ventricular Dysfunction Report Description The H1 2019 pipeline review report on Left Ventricular Dysfunction pipeline is a comprehensive ... detailed analysis on all active Left Ventricular Dysfunction pipeline compounds. The Left Ventricular Dysfunction pipeline guide presents ...

January 2019 50 pages

2019 Future of Meniere Disease R&D Pipeline Drugs and Companies- Analysis of Global Meniere Disease Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... into Phase 3 or Phase 4. Meniere Disease Report Description The H1 2019 pipeline review report on Meniere Disease pipeline is a comprehensive study on ... and actionable insights. Scope of Meniere Disease pipeline report includes An overview of Meniere Disease disease including symptoms, causes, diagnosis ...

January 2019 45 pages

2019 Future of Microscopic Polyangiitis (MPA) R&D Pipeline Drugs and Companies- Analysis of Global Microscopic Polyangiitis (MPA) Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... into Phase 3 or Phase 4. Microscopic Polyangiitis (MPA) Report Description The H1 2019 pipeline review report on Microscopic Polyangiitis (MPA) pipeline is a ... detailed analysis on all active Microscopic Polyangiitis (MPA) pipeline compounds. The Microscopic Polyangiitis (MPA) pipeline guide presents ...

January 2019 45 pages

2019 Future of Myocardial Fibrosis R&D Pipeline Drugs and Companies- Analysis of Global Myocardial Fibrosis Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... into Phase 3 or Phase 4. Myocardial Fibrosis Report Description The H1 2019 pipeline review report on Myocardial Fibrosis pipeline is a comprehensive study on ... and actionable insights. Scope of Myocardial Fibrosis pipeline report includes An overview of Myocardial Fibrosis disease including symptoms, causes, ...

January 2019 75 pages

2019 Future of Myocardial Ischemia R&D Pipeline Drugs and Companies- Analysis of Global Myocardial Ischemia Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... into Phase 3 or Phase 4. Myocardial Ischemia Report Description The H1 2019 pipeline review report on Myocardial Ischemia pipeline is a comprehensive study on ... and actionable insights. Scope of Myocardial Ischemia pipeline report includes An overview of Myocardial Ischemia disease including symptoms, causes, ...

January 2019 60 pages

2019 Future of Myocarditis R&D Pipeline Drugs and Companies- Analysis of Global Myocarditis Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... advancing their products into Phase 3 or Phase 4. Myocarditis Report Description The H1 2019 pipeline review report on Myocarditis pipeline is a comprehensive study on the candidates in development ...

January 2019 40 pages

2019 Future of Nasal Polyps R&D Pipeline Drugs and Companies- Analysis of Global Nasal Polyps Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... products into Phase 3 or Phase 4. Nasal Polyps Report Description The H1 2019 pipeline review report on Nasal Polyps pipeline is a comprehensive study on the ... clear and actionable insights. Scope of Nasal Polyps pipeline report includes An overview of Nasal Polyps disease including symptoms, causes, diagnosis ...

January 2019 60 pages

2019 Future of Nasopharyngitis (Common Cold) R&D Pipeline Drugs and Companies- Analysis of Global Nasopharyngitis (Common Cold) Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... into Phase 3 or Phase 4. Nasopharyngitis (Common Cold) Report Description The H1 2019 pipeline review report on Nasopharyngitis (Common Cold) pipeline is a comprehensive ... detailed analysis on all active Nasopharyngitis (Common Cold) pipeline compounds. The Nasopharyngitis (Common Cold) pipeline guide presents ...

January 2019 40 pages

2019 Future of Otitis Media R&D Pipeline Drugs and Companies- Analysis of Global Otitis Media Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... products into Phase 3 or Phase 4. Otitis Media Report Description The H1 2019 pipeline review report on Otitis Media pipeline is a comprehensive study on the ... clear and actionable insights. Scope of Otitis Media pipeline report includes An overview of Otitis Media disease including symptoms, causes, diagnosis ...

January 2019 60 pages

2019 Future of Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) R&D Pipeline Drugs and Companies- Analysis of Global Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... Phase 3 or Phase 4. Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Report Description The H1 2019 pipeline review report on Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD ...

January 2019 120 pages

2019 Future of Pressure Ulcers R&D Pipeline Drugs and Companies- Analysis of Global Pressure Ulcers Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... products into Phase 3 or Phase 4. Pressure Ulcers Report Description The H1 2019 pipeline review report on Pressure Ulcers pipeline is a comprehensive study on the ... and actionable insights. Scope of Pressure Ulcers pipeline report includes An overview of Pressure Ulcers disease including symptoms, causes, ...

January 2019 35 pages

2019 Future of Pruritus R&D Pipeline Drugs and Companies- Analysis of Global Pruritus Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... advancing their products into Phase 3 or Phase 4. Pruritus Report Description The H1 2019 pipeline review report on Pruritus pipeline is a comprehensive study on the candidates in development ...

January 2019 85 pages

2019 Future of Pulmonary Embolism R&D Pipeline Drugs and Companies- Analysis of Global Pulmonary Embolism Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... into Phase 3 or Phase 4. Pulmonary Embolism Report Description The H1 2019 pipeline review report on Pulmonary Embolism pipeline is a comprehensive study on ... and actionable insights. Scope of Pulmonary Embolism pipeline report includes An overview of Pulmonary Embolism disease including symptoms, causes, ...

January 2019 40 pages

2019 Future of Raynauds Disease R&D Pipeline Drugs and Companies- Analysis of Global Raynauds Disease Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... into Phase 3 or Phase 4. Raynauds Disease Report Description The H1 2019 pipeline review report on Raynauds Disease pipeline is a comprehensive study on ... and actionable insights. Scope of Raynauds Disease pipeline report includes An overview of Raynauds Disease disease including symptoms, causes, diagnosis ...

January 2019 40 pages

2019 Future of Restenosis R&D Pipeline Drugs and Companies- Analysis of Global Restenosis Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... advancing their products into Phase 3 or Phase 4. Restenosis Report Description The H1 2019 pipeline review report on Restenosis pipeline is a comprehensive study on the candidates in development ...

January 2019 45 pages

2019 Future of Rosacea R&D Pipeline Drugs and Companies- Analysis of Global Rosacea Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... of the Rosacea pipeline companies from advancing their products into Phase 3 or Phase 4. Rosacea Report Description The H1 2019 pipeline review ... report on Rosacea pipeline is a comprehensive study on the candidates ...

January 2019 60 pages

2019 Future of Scar R&D Pipeline Drugs and Companies- Analysis of Global Scar Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... of the Scar pipeline companies from advancing their products into Phase 3 or Phase 4. Scar Report Description The H1 2019 pipeline review ... report on Scar pipeline is a comprehensive study on the candidates ...

January 2019 75 pages

2019 Future of Secondary Hyperparathyroidism R&D Pipeline Drugs and Companies- Analysis of Global Secondary Hyperparathyroidism Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... advancing their products into Phase 3 or Phase 4. Secondary Hyperparathyroidism Report Description The H1 2019 pipeline review report on Secondary Hyperparathyroidism pipeline is a comprehensive study on the candidates in development ...

January 2019 40 pages

2019 Future of Sinusitis R&D Pipeline Drugs and Companies- Analysis of Global Sinusitis Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... advancing their products into Phase 3 or Phase 4. Sinusitis Report Description The H1 2019 pipeline review report on Sinusitis pipeline is a comprehensive study on the candidates in development ...

January 2019 75 pages

2019 Future of Thromboembolism R&D Pipeline Drugs and Companies- Analysis of Global Thromboembolism Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... advancing their products into Phase 3 or Phase 4. Thromboembolism Report Description The H1 2019 pipeline review report on Thromboembolism pipeline is a comprehensive study on the candidates in development ...

January 2019 75 pages

2019 Future of Tinnitus R&D Pipeline Drugs and Companies- Analysis of Global Tinnitus Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... advancing their products into Phase 3 or Phase 4. Tinnitus Report Description The H1 2019 pipeline review report on Tinnitus pipeline is a comprehensive study on the candidates in development ...

January 2019 50 pages

2019 Future of Vaso Occlusive Crisis Associated With Sickle Cell Disease R&D Pipeline Drugs and Companies- Analysis of Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... With Sickle Cell Disease Report Description The H1 2019 pipeline review report on Vaso-Occlusive Crisis Associated With Sickle Cell Disease pipeline is ... originating companies, license providers and universities participating in the Vaso-Occlusive Crisis Associated With Sickle Cell Disease product pipeline are ...

January 2019 75 pages

2019 Future of Venous Leg Ulcers (Crural ulcer) R&D Pipeline Drugs and Companies- Analysis of Global Venous Leg Ulcers (Crural ulcer) Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... products into Phase 3 or Phase 4. Venous Leg Ulcers (Crural ulcer) Report Description The H1 2019 pipeline review report on Venous Leg Ulcers (Crural ulcer) pipeline is a comprehensive ...

January 2019 60 pages

2019 Future of Ventricular Tachycardia R&D Pipeline Drugs and Companies- Analysis of Global Ventricular Tachycardia Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... into Phase 3 or Phase 4. Ventricular Tachycardia Report Description The H1 2019 pipeline review report on Ventricular Tachycardia pipeline is a comprehensive study ... insights. Scope of Ventricular Tachycardia pipeline report includes An overview of Ventricular Tachycardia disease including symptoms, causes ...

January 2019 50 pages

2019 Future of Vitiligo R&D Pipeline Drugs and Companies- Analysis of Global Vitiligo Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments

US$ 2,199.00

... advancing their products into Phase 3 or Phase 4. Vitiligo Report Description The H1 2019 pipeline review report on Vitiligo pipeline is a comprehensive study on the candidates in development ...

January 2019 65 pages

African Trypanosomiasis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for African Trypanosomiasis

US$ 1,200.00

African Trypanosomiasis Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of African Trypanosomiasis Infection pipeline products. DISEASE OVERVIEW African Trypanosomiasis infection is spread through Clostridium tetani bacteria ...

September 2018 65 pages

Bacillary Dysentery (Shigellosis) Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Bacillary Dysentery (Shigellosis)

US$ 1,200.00

Bacillary Dysentery (Shigellosis) Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Bacillary Dysentery (Shigellosis) Infection pipeline products. DISEASE OVERVIEW Bacillary Dysentery (Shigellosis) infection is spread through ...

September 2018 65 pages

Bacterial Vaginosis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Bacterial Vaginosis

US$ 1,200.00

Bacterial Vaginosis Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Bacterial Vaginosis Infection pipeline products. DISEASE OVERVIEW Bacterial Vaginosis infection is spread through Clostridium tetani bacteria ...

September 2018 65 pages

Candidiasis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Candidiasis

US$ 1,200.00

Candidiasis Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Candidiasis Infection pipeline products. DISEASE OVERVIEW Candidiasis infection is spread through Clostridium tetani bacteria, which ...

September 2018 65 pages

Cholera Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Cholera

US$ 1,200.00

Cholera Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Cholera Infection pipeline products. DISEASE OVERVIEW Cholera infection is spread through Clostridium tetani bacteria, which ...

September 2018 65 pages

Coccidioidomycosis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Coccidioidomycosis

US$ 1,200.00

Coccidioidomycosis Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Coccidioidomycosis Infection pipeline products. DISEASE OVERVIEW Coccidioidomycosis infection is spread through Clostridium tetani bacteria, which ...

September 2018 65 pages

Cryptococcosis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Cryptococcosis

US$ 1,200.00

Cryptococcosis Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Cryptococcosis Infection pipeline products. DISEASE OVERVIEW Cryptococcosis infection is spread through Clostridium tetani bacteria, which ...

September 2018 65 pages

Eastern Equine Encephalitis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Eastern Equine Encephalitis

US$ 1,200.00

Eastern Equine Encephalitis Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Eastern Equine Encephalitis Infection pipeline products. DISEASE OVERVIEW Eastern Equine Encephalitis infection is spread through Clostridium ...

September 2018 65 pages

Epstein–Barr Virus (HHV-4) Infections Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Epstein–Barr Virus (HHV-4) Infections

US$ 1,200.00

... format. SCOPE OF EPSTEIN–BARR VIRUS (HHV-4) INFECTIONS INFECTION PIPELINE REPORT INCLUDES Panorama of Epstein–Barr Virus (HHV-4) Infections Infection pipeline markets including statistics on therapeutic drugs and companies involved Epstein–Barr Virus (HHV-4) Infections Infection Pipeline candidates across ...

September 2018 65 pages

Equine Encephalitis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Equine Encephalitis

US$ 1,200.00

Equine Encephalitis Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Equine Encephalitis Infection pipeline products. DISEASE OVERVIEW Equine Encephalitis infection is spread through Clostridium tetani bacteria ...

September 2018 65 pages

Genital Herpes Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Genital Herpes

US$ 1,200.00

Genital Herpes Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Genital Herpes Infection pipeline products. DISEASE OVERVIEW Genital Herpes infection is spread through Clostridium tetani bacteria ...

September 2018 65 pages

Gonorrhea Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Gonorrhea

US$ 1,200.00

Gonorrhea Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Gonorrhea Infection pipeline products. DISEASE OVERVIEW Gonorrhea infection is spread through Clostridium tetani bacteria, which ...

September 2018 65 pages

Influenza A Virus H3N2 Subtype Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Influenza A Virus H3N2 Subtype

US$ 1,200.00

... . SCOPE OF INFLUENZA A VIRUS H3N2 SUBTYPE INFECTION PIPELINE REPORT INCLUDES Panorama of Influenza A Virus H3N2 Subtype Infection pipeline markets including statistics on therapeutic drugs and companies involved Influenza A Virus H3N2 Subtype Infection Pipeline ...

September 2018 65 pages

Influenza A virus H5N1 subtype Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Influenza A virus H5N1 subtype

US$ 1,200.00

... . SCOPE OF INFLUENZA A VIRUS H5N1 SUBTYPE INFECTION PIPELINE REPORT INCLUDES Panorama of Influenza A virus H5N1 subtype Infection pipeline markets including statistics on therapeutic drugs and companies involved Influenza A virus H5N1 subtype Infection Pipeline ...

September 2018 65 pages

Influenza A Virus H7N9 Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Influenza A Virus H7N9

US$ 1,200.00

... format. SCOPE OF INFLUENZA A VIRUS H7N9 INFECTION PIPELINE REPORT INCLUDES Panorama of Influenza A Virus H7N9 Infection pipeline markets including statistics on therapeutic drugs and companies involved Influenza A Virus H7N9 Infection Pipeline candidates across ...

September 2018 65 pages

Lassa Hemorrhagic Fever Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Lassa Hemorrhagic Fever

US$ 1,200.00

Lassa Hemorrhagic Fever Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Lassa Hemorrhagic Fever Infection pipeline products. DISEASE OVERVIEW Lassa Hemorrhagic Fever infection is spread through Clostridium ...

September 2018 65 pages

Marburgvirus Infections Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Marburgvirus Infections

US$ 1,200.00

... ready to use format. SCOPE OF MARBURGVIRUS INFECTIONS INFECTION PIPELINE REPORT INCLUDES Panorama of Marburgvirus Infections Infection pipeline markets including statistics on therapeutic drugs and companies involved Marburgvirus Infections Infection Pipeline candidates across various development ...

September 2018 65 pages

Meningitis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Meningitis

US$ 1,200.00

Meningitis Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Meningitis Infection pipeline products. DISEASE OVERVIEW Meningitis infection is spread through Clostridium tetani bacteria, which ...

September 2018 65 pages

Osteomyelitis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Osteomyelitis

US$ 1,200.00

Osteomyelitis Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Osteomyelitis Infection pipeline products. DISEASE OVERVIEW Osteomyelitis infection is spread through Clostridium tetani bacteria, which ...

September 2018 65 pages

Filters

Search

Categories

1,428
60
12,968
1,223
4,429
2
1
12,593
2,818
15,138
67
8,921
1
1,229
586

Publishers

61,464

Regions

1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
61,427

Price

Date

Pages

Offers